Watanabe Tomohiro, Yamashita Kouhei, Arai Yasuyuki, Minaga Kosuke, Kamata Ken, Nagai Tomoyuki, Komeda Yoriaki, Takenaka Mamoru, Hagiwara Satoru, Ida Hiroshi, Sakurai Toshiharu, Nishida Naoshi, Strober Warren, Kudo Masatoshi
Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka 589-8511, Japan;
Mucosal Immunity Section, Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; and.
J Immunol. 2017 May 15;198(10):3886-3896. doi: 10.4049/jimmunol.1700060. Epub 2017 Apr 3.
In previous studies, we found that human IgG4-related autoimmune pancreatitis (AIP) and murine AIP are driven by activation of plasmacytoid dendritic cells (pDCs) producing IFN-α. In the present studies we examined additional roles of pDC-related mechanisms in AIP pathogenesis, particularly those responsible for induction of fibrosis. We found that in murine AIP (MRL/Mp mice treated with polyinosinic-polycytidylic acid) not only the pancreatic infiltration of immune cells but also the development of fibrosis were markedly reduced by the depletion of pDCs or blockade of type I IFN signaling; moreover, such treatment was accompanied by a marked reduction of pancreatic expression of IL-33. Conversely, polyinosinic-polycytidylic acid-induced inflamed pancreatic tissue in murine AIP exhibited increased expression of type I IFNs and IL-33 (and downstream IL-33 cytokines such as IL-13 and TGF-β1). pDCs stimulated by type I IFN were the source of the IL-33 because purified populations of these cells isolated from the inflamed pancreas produced a large amount of IL-33 upon activation by TLR9 ligands, and such production was abrogated by the neutralization of type I IFN. The role of IL-33 in murine AIP pathogenesis was surprisingly important because blockade of IL-33 signaling by anti-ST2 Ab attenuated both pancreatic inflammation and accompanying fibrosis. Finally, whereas patients with both conventional pancreatitis and IgG4-related AIP exhibited increased numbers of acinar cells expressing IL-33, only the latter also exhibited pDCs producing this cytokine. These data thus suggest that pDCs producing IFN-α and IL-33 play a pivotal role in the chronic fibro-inflammatory responses underlying murine AIP and human IgG4-related AIP.
在先前的研究中,我们发现人类IgG4相关自身免疫性胰腺炎(AIP)和小鼠AIP是由产生IFN-α的浆细胞样树突状细胞(pDCs)激活所驱动的。在本研究中,我们探讨了pDC相关机制在AIP发病机制中的其他作用,特别是那些与纤维化诱导相关的机制。我们发现,在小鼠AIP(用聚肌苷酸-聚胞苷酸处理的MRL/Mp小鼠)中,通过清除pDCs或阻断I型干扰素信号,不仅免疫细胞在胰腺的浸润明显减少,而且纤维化的发展也显著降低;此外,这种治疗伴随着胰腺中IL-33表达的显著降低。相反,聚肌苷酸-聚胞苷酸诱导的小鼠AIP炎症胰腺组织中I型干扰素和IL-33(以及下游IL-33细胞因子如IL-13和TGF-β1)的表达增加。I型干扰素刺激的pDCs是IL-33的来源,因为从炎症胰腺中分离出的这些细胞纯化群体在被TLR9配体激活后会产生大量IL-33,而这种产生可通过中和I型干扰素来消除。IL-33在小鼠AIP发病机制中的作用出人意料地重要,因为抗ST2抗体阻断IL-33信号可减轻胰腺炎症和伴随的纤维化。最后,虽然传统胰腺炎患者和IgG4相关AIP患者的表达IL-33的腺泡细胞数量均增加,但只有后者也表现出产生这种细胞因子的pDCs。因此,这些数据表明,产生IFN-α和IL-33的pDCs在小鼠AIP和人类IgG4相关AIP潜在的慢性纤维炎症反应中起关键作用。